Implenia AG | WebDisclosure

Basculer en Français

8601	Companies
140631	Keywords
76564	Articles
75122	Press releases

Home
Companies
Implenia AG

BRIEF

published on 04/03/2025 at 07:05, 4 days 7 hours ago

Tunnel Ostbahnhof consortium wins new contract in Munich

Tunnel Construction Implenia HOCHTIEF Ostbahnhof Tunnel Consortium Munich RER
BRIEF

published on 04/03/2025 at 07:05, 4 days 7 hours ago

Le consortium Tunnel Ostbahnhof décroche un nouveau contrat à Munich

Implenia Consortium Tunnel Ostbahnhof HOCHTIEF RER De Munich Construction De Tunnels
PRESS RELEASE

published on 04/03/2025 at 07:00, 4 days 7 hours ago

“Tunnel Ostbahnhof” joint venture awarded contract for eastern section of the Second Core S-Bahn Route in Munich
Implenia AG's joint venture awarded major contract for 'Tunnel Ostbahnhof' project as part of the Second Core S-Bahn Route in Munich, worth hundreds of millions of euros. Construction begins in June 2025 and aims for completion by May 2033

Implenia AG Munich Deutsche Bahn Tunnel Ostbahnhof Second Core S-Bahn Route
PRESS RELEASE

published on 04/03/2025 at 07:00, 4 days 7 hours ago

Le consortium Tunnel Ostbahnhof remporte le marché du tronçon Est de la 2e ligne principale du RER de Munich
La Deutsche Bahn attribue le marché du tronçon Est de la 2e ligne principale du RER de Munich au consortium Tunnel Ostbahnhof, composé d'Implenia et HOCHTIEF

Marché Implenia Deutsche Bahn RER De Munich Tunnel Ostbahnhof
BRIEF

published on 03/31/2025 at 18:05, 6 days 20 hours ago

Implenia AG Issues CHF 220 Million Bond in Swiss Market

Swiss Market Financing Structure Bonds Issuance Implenia Bond CHF 220 Million
BRIEF

published on 03/31/2025 at 18:05, 6 days 20 hours ago

Implenia SA émet un emprunt obligataire de 220 millions de francs suisses sur le marché suisse

Marché Suisse Emission D'obligations Structure De Financement Obligation Implenia 220 Millions De Francs Suisses
PRESS RELEASE

published on 03/31/2025 at 18:00, 6 days 20 hours ago

Implenia place un emprunt obligataire de CHF 220 millions
Implenia place un emprunt obligataire de CHF 220 millions avec un taux d'intérêt de 2,50% pour renforcer sa structure de financement

Emprunt Obligataire Implenia Taux D'intérêt Structure De Financement CHF 220 Millions
PRESS RELEASE

published on 03/31/2025 at 18:00, 6 days 20 hours ago

Implenia places CHF 220 million bond
Implenia successfully places CHF 220 million bond with 2.50% coupon, improving financing structure. Bond to be listed on SIX Swiss Exchange

Financing Bond Implenia SIX Swiss Exchange CHF 220 Million
BRIEF

published on 03/27/2025 at 07:05, 11 days 7 hours ago

Implenia Secures New Contracts in Key Sectors

Data Centres Implenia Infrastructure Projects Healthcare Construction Hydropower Plant
BRIEF

published on 03/27/2025 at 07:05, 11 days 7 hours ago

Implenia remporte de nouveaux contrats dans des secteurs clés

Implenia Centres De Données Construction De Soins De Santé Centrale Hydroélectrique Projets D'infrastructure

Accesswire

Published on 04/07/2025 at 14:30, 13 minutes ago

Newsmax Enters into Standby Equity Purchase Agreement of Up to $1.2 Billion With Yorkville Advisors
Published on 04/07/2025 at 14:30, 13 minutes ago

Sparta Provides Update on Delay in Filing Annual Financial Statements
Published on 04/07/2025 at 14:00, 43 minutes ago

NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
Published on 04/07/2025 at 14:00, 43 minutes ago

Rio Grande Resources Announces the Successful Completion of Sampling and Field Campaign at the Winston Gold-Silver Project
Published on 04/07/2025 at 14:00, 43 minutes ago

Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology

View all ACCESSWIRE

EQS Group

Published on 04/07/2025 at 14:26, 16 minutes ago

Share Buyback
Published on 04/07/2025 at 14:24, 18 minutes ago

OTRS AG: Voluntary Public Tender Offer of Optimus BidCo AG
Published on 04/07/2025 at 13:00, 1 hour 43 minutes ago

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Published on 04/07/2025 at 12:57, 1 hour 45 minutes ago

PFISTERER acquires long-standing partner Power CSL - portfolio expanded to include subsea solutions
Published on 04/07/2025 at 11:57, 2 hours 45 minutes ago

Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014

Les Echos

Published on 04/07/2025 at 07:01, 7 hours 42 minutes ago

bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 7 hours 42 minutes ago

bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 19 hours ago

Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 19 hours ago

Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 20 hours ago

Reporting on share buyback transactions carried out between March 31 and April 3, 2025

View all LES ECHOS COMFI WIRE